Bladder cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) |
||
| (10 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Bladder cancer}} | {{Bladder cancer}} | ||
{{SCC}} | {{CMG}}, {{SCC}} {{AE}} {{F.K}}, {{SC}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of bladder cancer include blood in the urine and abnormal cells in urine cytology. [Tumor marker]] tests include ladder tumour–associated antigen (BTA), uclear matrix proteins (NMP) and mucin and carcinoembryonic antigen (CEA). | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
*Laboratory findings consistent with the diagnosis of bladder cancer include:<ref name="pmid18660854">{{cite journal |vauthors=Shariat SF, Karam JA, Lotan Y, Karakiewizc PI |title=Critical evaluation of urinary markers for bladder cancer detection and monitoring |journal=Rev Urol |volume=10 |issue=2 |pages=120–35 |date=2008 |pmid=18660854 |pmc=2483317 |doi= |url=}}</ref><ref name="pmid20161673">{{cite journal |vauthors=Villicana P, Whiting B, Goodison S, Rosser CJ |title=Urine-based assays for the detection of bladder cancer |journal=Biomark Med |volume=3 |issue=3 |pages=265 |date=June 2009 |pmid=20161673 |pmc=2819730 |doi=10.2217/bmm.09.23 |url=}}</ref><ref name="pmid11306356">{{cite journal |vauthors=Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR |title=Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology |journal=Urology |volume=57 |issue=4 |pages=599–603 |date=April 2001 |pmid=11306356 |doi= |url=}}</ref> | |||
* Complete blood count | |||
:* Low [[red blood cell]] count | |||
:*Elevated [[alkaline phosphatase]] | |||
* [[Urinalysis]] | * [[Urinalysis]] | ||
:* | :* Hematuria | ||
* Urine cytology | * Urine cytology | ||
:* | :* Abnormal cells in the urine | ||
* | * [[Tumor marker]] tests | ||
:* Bladder tumour–associated antigen (BTA) | :* Bladder tumour–associated antigen (BTA) | ||
:* Nuclear matrix proteins (NMP) | :* Nuclear matrix proteins (NMP) | ||
:* Mucin and carcinoembryonic antigen (CEA) | :* Mucin and carcinoembryonic antigen (CEA) | ||
==References== | ==References== | ||
| Line 26: | Line 28: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Urology]] | [[Category:Urology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Nephrology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 15:12, 25 July 2018
|
Bladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bladder cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Bladder cancer laboratory findings |
|
Risk calculators and risk factors for Bladder cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Farima Kahe M.D. [2], Shanshan Cen, M.D. [3]
Overview
Laboratory findings consistent with the diagnosis of bladder cancer include blood in the urine and abnormal cells in urine cytology. [Tumor marker]] tests include ladder tumour–associated antigen (BTA), uclear matrix proteins (NMP) and mucin and carcinoembryonic antigen (CEA).
Laboratory Findings
- Laboratory findings consistent with the diagnosis of bladder cancer include:[1][2][3]
- Complete blood count
- Low red blood cell count
- Elevated alkaline phosphatase
- Hematuria
- Urine cytology
- Abnormal cells in the urine
- Tumor marker tests
- Bladder tumour–associated antigen (BTA)
- Nuclear matrix proteins (NMP)
- Mucin and carcinoembryonic antigen (CEA)
References
- ↑ Shariat SF, Karam JA, Lotan Y, Karakiewizc PI (2008). "Critical evaluation of urinary markers for bladder cancer detection and monitoring". Rev Urol. 10 (2): 120–35. PMC 2483317. PMID 18660854.
- ↑ Villicana P, Whiting B, Goodison S, Rosser CJ (June 2009). "Urine-based assays for the detection of bladder cancer". Biomark Med. 3 (3): 265. doi:10.2217/bmm.09.23. PMC 2819730. PMID 20161673.
- ↑ Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR (April 2001). "Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology". Urology. 57 (4): 599–603. PMID 11306356.